Neuro-Cells therapy improves motor outcomes and suppresses inflammation during experimental syndrome of amyotrophic lateral sclerosis in mice

Johannes P. J. M. de Munter, Igor Shafarevich, Alexei Liundup, Dmitrii Pavlov, Erik Ch Wolters, Anna Gorlova, Ekaterina Veniaminova, Aleksei Umriukhin, Allan Kalueff, Andrei Svistunov, Boris W. Kramer, Klaus-Peter Lesch, Tatyana Strekalova

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)504-517
Number of pages14
JournalCNS Neuroscience & Therapeutics
Volume26
Issue number5
Early online date23 Dec 2019
DOIs
Publication statusPublished - May 2020

Keywords

  • amyotrophic lateral sclerosis (ALS)
  • fused in sarcoma (FUS) protein
  • glycogen-synthase kinase-3 ss (GSK-3 ss)
  • microglia activation
  • mouse
  • stem cell therapy
  • superoxide dismutase-1 (SOD-1) G93A mice
  • MESENCHYMAL STEM-CELLS
  • MARROW STROMAL CELLS
  • INJURED SPINAL-CORD
  • MOUSE MODEL
  • TRANSPLANTATION
  • MUTATIONS
  • PHENOTYPE
  • STRESS
  • TRIAL

Cite this